The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection

Infectious Disease Clinics of North America

Volumn 12, Issue 3, 1998, Pages 569-592

  File T M , Jr ^a   Tan, J S ^a   Plouffe, J F ^a  

^a SUMMA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GREPAFLOXACIN; LEVOFLOXACIN; OFLOXACIN; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN;

ANTIBIOTIC THERAPY; CHLAMYDOPHILA PNEUMONIAE; HUMAN; INFECTION COMPLICATION; INFECTIOUS PNEUMONIA; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIAE; RESPIRATORY TRACT INFECTION; REVIEW; SERODIAGNOSIS;

EID: 0031656435     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0891-5520(05)70199-9     Document Type: Review

References (128)

1. E.R. Alexander H.M. Foy G.E. Kenny Pneumoniae due to Mycoplasma pneumoniae N Engl J Med 275 1966 131 136
2. J. Almirall I. Morató F. Riera Incidence of community-acquired pneumonia and Chlamydia pneumoniae: A prospective multi-centre study Eur Respir J 6 1993 14 18
3. J.G. Bartlett L.M. Mundy Community-acquired pneumonia N Engl J Med 333 1995 1618 1624
4. J.G. Bartlett R.F. Breiman L.A. Mandell Community-acquired pneumoniae in adults: Guidelines for management Clin Infect Dis 26 1998 811 838
5. Birch ME, Goldman M, Hartstein AL, et al: Recovery of Chlamydia pneumoniae in culture of bronchoalveolar lavage specimens from immunosuppressed patients with pulmonary infiltrates. In Proceedings and abstracts of the 33rd Annual Meeting of the IDSA, San Francisco, September 1995
6. J. Blanquer R. Blanquer R. Borras An etiology of community-acquired pneumoniae in Valencia, Spain: A multicenter prospective study Thorax 46 1991 508 511
7. S. Block J. Hedrick M.R. Hammerschlag Comparative safety and efficacy of clarithromycin and erythromycin ethylsuccinate suspensions in the treatment of children with community-acquired pneumonia Pediatr Infect Dis J 14 1995 471 477
8. J. Boman A. Allard K. Persson Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA J Infect Dis 175 1997 1523 1526
9. S.J. Bourke N.F. Lightfoot Chlamydia pneumoniae: Defining the clinical spectrum of infection requires precise laboratory diagnosis Thorax 50 Suppl 1 1995 43 48
10. M. Bozzoni L. Radice A. Frost Prevalence of pneumonia due to Legionella pneumophila and Mycoplasma pneumoniae in a population admitted to a department of internal medicine Respiration 62 1995 331 335
11. J.A. Bridge P.H. Edelstein Oropharyngeal colonization with Legionella pneumophila J Clin Microbiol 18 1993 1108 1112
12. J.C. Butler B.S. Fields R.F. Breiman Prevention and control of legionellosis Infect Dis Clin Pract 6 1997 458 467
13. L.A. Campbell M.P. Mnelgosa D.J. Hamilton Detection of Chlamydia pneumoniae by polymerase chain reaction J Clin Microbiol 30 1992 434 439
14. L.A. Campbell E.R. O'Brien A.L. Cappuccio Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues J Infect Dis 172 1995 585 588
15. G.H. Cassell J. Drnec K.B. Waites Efficacy of clarithromycin against Mycoplasma pneumoniae J Antimicrob Chemother 27 Suppl A 1991 47 59
16. K. Chirgwin P.M. Roblin M. Gelling M.R. Hammerschlag J. Schachter Infection with Chlamydia pneumoniae in Brooklyn J Infect Dis 163 1991 757 761
17. N. Cimolai D. Wensley M. Seear Mycoplasma pneumoniae as a cofactor in severe respiratory infections Clin Infect Dis 21 1995 1182 1185
18. Clyde W.A. Jr Clinical overview of typical Mycoplasma pneumoniae infections Clin Infect Dis 17 Suppl 1 1993 32 36
19. R. Cosentini F. Blasi R. Raccanelli Severe community-acquired pneumonia: A possible role for Chlamydia pneumoniae Respiration 63 1996 61 65
20. B.A. Cunha A.M. Ortega Atypical pneumonia: Extrapulmonary clues guide the way to diagnosis Postgrad Med 99 1996 123 132
21. M.D. Eaton G. Meiklejohn W. VanHerick Studies on the etiology of primary atypical pneumonia: A filtrable agent transmissible to cotton rats, hamsters and chick embryos J Exp Med 79 1944 649 668
22. P.H. Edelstein Antimicrobial chemotherapy for Legionnaires' disease: A review Clin Infect Dis 21 Suppl 3 1995 5265 5276
23. A.C. England D.W. Fraser B.D. Plikaytis Sporadic legionellosis in the United States: The first thousand cases Ann Intern Med 94 1981 164 170
24. G.D. Fang M. Fine J. Orloff New and emerging etiologies for community-acquired pneumonia with implications for therapy: A prospective multicenter study of 359 cases Medicine 69 1990 307 316
25. B.M. Farr D.L. Kaiswer B.D.W. Harrison Prediction of microbial etiology at admission to hospital pneumonia from the presenting clinical features Thorax 44 1989 1031 1035
26. D. Felmingham M.J. Robbins K. Ingley In vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates J Antimicrob Chemotherapy 39 Suppl B 1997 43 49
27. P.B. Fernandes R. Bailer R. Swanson In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide Antimicrob Agents Chemother 30 1986 865 873
28. M.J. Ferraro Limitations in laboratory diagnosis of community-acquired pneumonia and acute exacerbations of chronic bronchitis Hosp Med 33 Suppl 2 1997 14 17
29. B.S. Fields The molecular ecology of legionellae Trends Microbiol 4 1996 286 290
30. File T.M. Jr Fluoroquinolones and respiratory tract infections: Do they work Infect Dis Clin Pract 6 Suppl 2 1997 59 66
31. File T.M. Jr J.S. Tan Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia Curr Opin Pulm Med 3 1997 89 97
32. File T.M. Jr J.G. Bartlett G.H. Cassell The importance of Chlamydia pneumoniae as a pathogen: The 1996 consensus conference on Chlamydia pneumoniae infection Infect Dis Clin Pract 6 2 Suppl 1997 28 31
33. File TM Jr, Plouffe JF, Breiman RF: Community-acquired pneumonia requiring hospitalization due to Chlamydia pneumoniae as the sole pathogen [abstract]. Presented at the Infectious Disease Society of America 33rd Annual Meeting, New Orleans, September, 1996
34. File T.M. Jr J. Segreti L. Dunbar A multicenter randomized study comparing the efficacy and safety of IV/po levofloxacin vs ceftriaxone/cefuroxime axetil in the treatment of adults with community-acquired pneumonia Antimicrob Agents Chemother 41 1997 1965 1972
35. File T.M. Jr J.S. Tan D.P. Murphy Atypical pneumonia syndrome Prim Care 8 1981 673 694
36. File T.M. Jr J.S. Tan J.F. Plouffe Community-acquired pneumonia: What's needed for accurate diagnosis Postgrad Med 99 1996 95 107
37. File T.M. Jr J.S. Tan J.F. Plouffe The etiology and impact of community-acquired pneumonia Cohen M.S. New challenges in Respiratory Tract Infection and Causative Pathogens 1997 The American Journal of Medicine Continuing Education Series. Excerpta Medica Office of Continuing Medical Education Belle Mead 3 11
38. M.J. Fine M.A. Smith C.A. Carson Prognosis and outcome of patients with community-acquired pneumoniae: A meta-analysis JAMA 275 1996 134 141
39. H.M. Foy G.E. Kenny R. McMahan Mycoplasma pneumoniae pneumonia in an urban area: Five years of surveillance JAMA 214 1970 1666
40. C.A. Gaydos T.C. Quinn J.J. Eiden Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene J Clin Microbiol 30 1992 796 800
41. C.A. Gaydos P.M. Roblin M.R. Hammerschlag Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients J Clin Microbiol 32 1994 903 905
42. C.A. Gaydos J.T. Summersgill N.N. Sahney Replication of Chlamydia pneumoniae in vitro human macrophages, endothelial cells, and aortic artery smooth muscle cells Infect Immunol 64 1996 1614 1620
43. A. Granados D. Podzamczer F. Gudiol Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: Similarities and differences in presentation Eur Respir J 2 1989 130 134
44. J.T. Grayston M.B. Aldous A. Easton Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis J Infect Dis 168 1993 1231 1235
45. J.T. Grayston V.K. Diwan M. Cooney Community-and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically Arch Intern Med 149 1989 169 173
46. J.T. Grayston C.C. Kuo S.P. Wang A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection N Engl J Med 315 1986 161 168
47. Gregory WW, Rosenstein RB, Flouty CE, et al and the Atypical Pneumonia Study Group: Azithromycin in the treatment of community-acquired pneumonia (CAP) due to Mycoplasma pneumoniae or Chlamydia pneumoniae [abstract]. Presented at the American Thoracic Society Annual Meeting, San Francisco, May 1997
48. S. Gupta E.W. Leatham D. Carrington Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction Circulation 96 1997 404 407
49. E. Gurfinkel G. Bozovich Daroca A. for the ROXIS Study Group Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study Lancet 350 1997 404 407
50. D.L. Hahn Evidence for Chlamydia pneumoniae in asthma Allegra L. Blasi F. Chlamydia pneumoniae infection 1995 Springer-Verlag Italia Milan 65 75
51. M.R. Hammerschlag Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae Antimicrob Agents Chemother 38 1994 1873 1878
52. M.R. Hammerschlag Atypical pneumonias in children Adv Pediatr Infect Dis 10 1995 1 39
53. M.R. Hammerschlag Diagnostic methods for intracellular pathogens Clin Microbiol Infect 1 1 Suppl 1996 3 8
54. M.R. Hammerschlag K. Chirgwin P.M. Roblin Persistent infection with Chlamydia pneumoniae following acute respiratory illness Clin Infect Dis 14 1992 178 182
55. M.R. Hammerschlag C.L. Hyman P.M. Roblin In vitro activities of five quinolones against Chlamydia pneumoniae Antimicrob Agents Chemother 36 1992 682 683
56. C.M. Helms J.P. Viner R.H. Sturm Comparative features of pneumococcal, mycoplasmal and Legionnaires' disease pneumonias Ann Intern Med 90 1979 543 547
57. C.M. Helms J.P. Viner D.D. Weisenburger Sporadic Legionnaires' disease: Clinical observations on 87 nosocomial and community-acquired cases Am J Med Sci 288 1984 2 12
58. C.L. Hyman M.H. Augenbraun P.M. Roblin Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR J Clin Microbiol 29 1991 2082 2083
59. C.L. Hyman P.M. Roblin C.A. Gaydos Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: Assessment by polymerase chain reaction-enzyme immunoassay and culture Clin Infect Dis 20 1995 1174 1178
60. L.A. Jackson J.T. Grayston Chlamydia pneumoniae and Mycoplasma pneumoniae infections Curr Opin Infect Dis 9 1996 89 93
61. E. Jacobs Serological diagnosis of Mycoplasma pneumoniae infections: A critical review of Current Procedures Clin Infect Dis 17 Suppl 1 1993 79 82
62. R.N. Jones In vitro activity of new macrolides against respiratory pathogens Infect Med 9 Suppl A 1992 13 19
63. M.T. Kauppinen P. Saikku Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment Clin Infect Dis 21 1995 S244 S252
64. M.T. Kauppinen E. Herva P. Kujala The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland J Infect Dis 172 1995 1330 1335
65. M.T. Kauppinen P. Saikku P. Kujala Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pneumococcal pneumonia Thorax 51 1996 185 189
66. D.W. Keller R. Hajjeh A. DeMaria Community outbreak of Legionnaires' disease: An investigation confirming the potential for cooling towers to transmit Legionella species Clin Infect Dis 22 1996 257 261
67. Keller DW, Lipman HB, Marston BJ, et al: Clinical diagnosis of Legionnaires' disease (LD) using a multivariate model [abstract]. Abstracts of the 35th Interscience on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology. San Francisco, September, 1995
68. C.C. Kuo L.A. Jackson L.A. Campbell Chlamydia pneumoniae (TWAR) Clin Microbiol Rev 8 1995 451 461
69. C.C. Kuo L.A. Jackson A. Lee J.T. Grayston In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae Antimicrob Agents Chemother 40 1996 2669 2670
70. D.B. Langille L. Yates T.J. Marrie Serological investigation of pneumonia as it presents to the physician's office Can J Infect Dis 4 1995 328 332
71. D. Lieberman D. Lieberman Atypical pathogen pneumonia Curr Opin Pulm Med 3 1997 111 116
72. D. Lieberman F. Schlaeffer I. Boldur Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients Thorax 51 1996 179 184
73. E. Linnanmäki M. Leinonen K. Mattila Chlamydia pneumoniae- specific circulating immune complexes in patients with chronic coronary heart disease Circulation 87 1993 1130 1134
74. C. Liu Mycoplasmal pneumonia Hoeprich P.D. Jordan M.C. Ronald A.R. Infectious Diseases ed 5 1994 JB Lippincott Philadelphia
75. J.M. Llibre A. Urban E. Garcia Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection Clin Infect Dis 25 1997 1340 1342
76. J.T. MacFarlane A.C. Miller Roderick Smith W.H. Comparative radiographic features of community-acquired Legionnaires' disease, pneumococcal pneumonia, Mycoplasma pneumonia, and psittacosis Thorax 81 1984 133 139
77. R. Malinverni C.C. Kuo L.A. Campbell Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone J Infect Dis 172 1995 593 594
78. P.E. Marik J. Iglesias Severe community-acquired pneumonia, shock and multiorgan dysfunction syndrome caused by Chlamydia pneumoniae J Intern Med 241 1997 441 444
79. T.J. Marrie Atypical pneumonia revisited Semin Respir Crit Care Med 17 1996 221 229
80. T.J. Marrie Community-acquired pneumonia Clin Infect Dis 18 1994 501 515
81. T.J. Marrie Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly Arch Intern Med 153 1993 488 494
82. T.J. Marrie J.T. Grayston S.P. Wang Pneumonia associated with the TWAR strain of Chlamydia Ann Intern Med 106 1987 507 511
83. T.J. Marrie R.W. Peeling M.J. Fine Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course Am J Med 101 1996 508 515
84. B.J. Marston H.B. Lipman R.F. Breiman Surveillance for Legionnaires' disease Arch Intern Med 154 1994 2417 2422
85. B.J. Marston J.F. Plouffe File T.M. Jr Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based active surveillance study in Ohio Arch Intern Med 157 1997 1709 1718
86. G. Martens S.J. Lewis deGoveia C. “Atypical” bacteria are a common cause of community-acquired pneumonia in hospitalized adults S Afr Med J 84 1994 678 682
87. R.E. Martin J.H. Bates Atypical pneumonia Infect Dis Clin North Am 5 1991 585
88. McConnell C.T. Jr J.F. Plouffe File T.M. for the CBPIS Study Group Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections Radiology 192 1994 819 824
89. R.D. Meyer Role of the quinolones in the treatment of legionellosis J Antimicrob Chemother 28 1991 623 624
90. R.L. Moolenaar C. Dalton H.B. Lipman Clinical features that differentiate Hantavirus pulmonary syndrome from three other acute respiratory illnesses Clin Infect Dis 21 1995 643 649
91. R.R. Muder V.L. Yu A.H. Woo Mode of transmission of Legionella pneumophila Arch Intern Med 146 1986 1607 1612
92. L.M. Mundy P.G. Auwaerter D. Oldach Community-acquired pneumonia impact of immune status Am J Respir Crit Care Med 152 1995 1309 1315
93. H.W. Murray H. Masur L.B. Senterfit The protean manifestations of Mycoplasma pneumoniae infection in adults Am J Med 58 1975 229 242
94. M.S. Niederman J.B. Bass G.D. Campbell Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy Am Rev Respir Dis 148 1993 1418 1426
95. J.F. Plouffe Legionnaires' disease and related infections Hoeprich P.D. Jordan M.C. Ronald A.R. Infectious Diseases ed 5 1994 JB Lippincott Philadelphia
96. J.F. Plouffe T.M. File R.F. Breiman Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay Clin Infect Dis 20 1995 1286 1291
97. T.C. Quinn Diagnosis of atypical pneumonias: Legionella, Chlamydia , and Mycoplasma infections Ann Intern Med 124 1996 585 599
98. Ramirez J.A. the Chlamydia pneumoniae/Atherosclerosis Study Group Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis Ann Intern Med 125 1996 979 982
99. J.A. Ramirez S. Ahkee A. Tolentino Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen Diag Microbiol Infect Dis 24 1996 7 14
100. Ramsey K.M. deShazo R.D. Chlamydia pneumoniae: New diagnostic tools for detection of a common pathogen Chest 110 3 1996 593 594
101. H.A. Reiman An acute infection of the respiratory tract with atypical pneumonia JAMA 26 1938 2377 2384
102. J. Retsema A. Girard W. Schelkly Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms Antimicrob Agents Chemother 31 1987 1939 1947
103. P.M. Roblin W. Dumornay M. Hammerschlag Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae J Clin Microbiol 30 1992 1968 1971
104. J. Roig A. Carreres C. Domingo Treatment of Legionnaires' disease Drugs 46 1993 63 79
105. J. Roig C. Domingo J. Morera Legionnaires' disease Chest 105 1994 1817 1825
106. A. Ruiz-Gonzalez M. Falguera A. Nogues Prediction of microbial etiology for community-acquired pneumonia from the presenting clinical features Eur Respir J 9 Suppl 23 1996 4
107. P. Saikku M. Leinonen K. Mattila Serological evidence of an association of a novel Chlamydia , TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 983 986
108. J.M. Shames R.B. George W.B. Holliday Comparison of antibiotics in the treatment of mycoplasmal pneumonia Arch Intern Med 125 1970 680 684
109. K.N. Shands J.L. Ho R.D. Meyer Potable water as a source of Legionnaires' disease JAMA 253 1985 1412 1416
110. C.B. Smith W.T. Friedwell R.M. Chanock Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin N Engl J Med 276 1967 1172 1175
111. D. Steinhoff H. Lode G. Rudeschel Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin Clin Infect Dis 72 1996 958 964
112. J.E. Stout V.L. Yu Legionellosis N Engl J Med 337 1997 682 687
113. W.L. Straus J.F. Plouffe T.M. File Risk factors for domestic acquisition of Legionnaires' disease Arch Intern Med 156 1996 1685 1692
114. J. Tew L. Calenoff B.S. Berlin Bacterial or non-bacterial pneumonia: Accuracy of radiographic diagnosis Radiology 124 1977 607 612
115. D.H. Thom J.T. Grayston D.S. Siscovick Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease JAMA 268 1992 68 72
116. A. Torres J. Dorca R. Zalacain Community-acquired pneumonia in chronic obstructive pulmonary disease: A Spanish multicenter study Am J Respir Crit Care Med 154 1996 1456 1461
117. C.J. Troy R.W. Peeling A.G. Ellis Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes JAMA 277 1997 1214 1218
118. K.E. Unertl F.P. Lenhart H. Forst Brief report: Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin Am J Med 87 Suppl 5A 1989 128 131
119. L. VonHertzen H. Alakarppa R. Koskinen Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease Epidemiol Infect 118 1997 155 164
120. Weiss SM, Quist J, Roblin P, et al: The relationship between Chlamydia pneumoniae (Cp) and bronchospasm in adults [abstract]. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September, 1995
121. S.M. Weiss P.M. Roblin C.A. Gaydos Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy J Infect Dis 173 1996 957 962
122. L. Welsh C. Gaydos T.C. Quinn In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae Antimicrob Agents Chemother 40 1996 212 214
123. M.A. Woodhead Atypical pneumonia Curr Opin Infect Dis 10 1997 101 102
124. M.A. Woodhead J.T. MacFarlane Comparative clinical and laboratory features of Legionella with pneumococcal and Mycoplasma pneumonias Br J Dis Chest 81 1987 133 139
125. S.W. Wright K.M. Edwards M.D. Decker Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough Acad Emer Med 4 1997 179 183
126. Z.P. Yang C.C. Kuo J.T. Grayston A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis Infect Immunol 61 1993 2037 2040
127. Z.P. Yang P.K. Cummings D.L. Patton Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice J Infect Dis 170 1994 464 467
128. Z.P. Yang C.C. Kuo J.T. Grayston Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice J Infect Dis 171 1995 736 738